Search Results
Results found for "Gillman lab"
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
Paul Insel's lab at UC San Diego has pursued this question using unbiased expression profiling — GPCR His lab combines bioinformatic analysis of GPCR expression across human cancers with wet-lab validation Insel's lab examined GPCR expression across 45 human cancer types and found widespread over expression The group needed someone to visit Gilman's lab to learn radioligand binding — and he was the one with ’s lab .
- Dr. Gregory Tall | Dr. GPCR Ecosystem
conduct his postdoctoral work on heterotrimeric G proteins and the novel interactor, Ric-8 with Alfred Gilman of Pharmacology and Physiology at the University of Rochester Medical Center, there establishing his lab The current goals of the Tall lab are to understand the basic mechanism by which Ric-8 proteins fold Gregory Tall on the web The Tall Lab University of Michigan Google Scholar Twitter Dr.
- Dr. Roger Sunahara | Dr. GPCR Ecosystem
He later joined the laboratory of eminent biochemical pharmacologist, Dr. Alfred G. Gilman, at the University of Texas Southwestern Medical School as a post-doctoral fellow. The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G The Sunahara lab has also been developing protein-based therapeutics using structure-guided design and Through structural and computational approaches the Sunahara lab and collaborators developed a thermostable
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
When his lab closed in 2020, Dr. Paul Insel turned dry-lab science into a reframing of COVID-19 pathobiology as a GPCR signaling imbalance Paul Insel did something unusual for a working lab scientist: he stopped pipetting, and started writing Beyond the lab, he has been a long-standing contributor to the Goodman & Gilman textbook of pharmacology It is exactly the kind of work a pharmacologist does when the lab is closed.
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
Trained in the Gelman lab at the University of Wisconsin-Madison and later in the Ploegh lab at Harvard This is the central mechanistic priority he is bringing to his NIH lab. 5. He completed his postdoctoral training at MIT and Harvard Med School in the lab of Hidde Ploegh , where He earned his Ph.D. in Chemistry at the University of Wisconsin-Madison in the lab of Sam Gellman on Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr.
- Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem
The foundation of this program rests on a serendipitous discovery Boucard made in Thomas Südhof's lab The Black Widow Toxin Nobody Put Together Working in Südhof's lab on cell adhesion molecules, Boucard Boucard describes this breadth not as an opportunity but as a constraint: the challenge for his lab has Boucard´s lab focuses on molecular and cellular mechanisms underlying the function of adhesion GPCRs Having a particular interest for a three-member family named latrophilins, his lab seeks to decipher
- Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect | Dr. GPCR Ecosystem
Graciela Pineyro shares what a forced lab shutdown taught her about prioritization, remote lab meetings Zoom did not flatten the lab. It flattened the hierarchy of who gets heard. The personal cost doesn't stay outside the lab. Dr. Running a lab during the pandemic was rarely just a scientific problem. Lab on Pubmed Dr.
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Silvio Gutkind on keeping a cancer research lab running at 10% occupancy, why rotation students act like Every lab member needed a contract. Silvio Gutkind on the web Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications More Publications from the Gutkind Lab on Pubmed Dr. J Silvio Gutkind on LinkedIn Gutkind Lab on Twitter UCSD Moores Cancer Center Dr.
- Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem
. << Back to podcast list Strategic Partner(s) Yamina Berchiche: Beyond the Lab — From Chemokine Receptors Michel Bouvier's lab on BRET-based conformational readouts. Berchiche didn't get in Michel Bouvier's lab led her to Nikolaus Heveker's newly opened lab at CHU Sainte-Justine After nearly two decades in the lab, Dr. Without that tissue, GPCRs stay siloed by receptor family and by lab.
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
He is currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of : 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical Soc.); 2014 Goodman and Gilman
- GPCR University Group Package | Dr. GPCR Ecosystem
GPCR Premium access for your entire academic lab. Teach a course at Dr. GPCR Premium — Free for Your Entire Lab Empowering academic discoveries with industry-grade GPCR resources We want to support academic labs with the same high-quality tools, courses, and insights used by leading GPCR Academic Team Access Program gives your entire lab one year of Premium membership at no cost, in Book Ready to Unlock Premium for Your Entire Lab—At No Cost?
- Dr. Daniel Wacker | Dr. GPCR Ecosystem
Daniel Wacker I obtained my B.Sc. degree from the University of Munich performing work in the lab of Roland Beckmann with a brief stay at Cambridge University, UK, working in the lab of the late Dr. I next moved to Rockefeller University in NYC to work in the lab of the late Dr. There I obtained my Ph.D. in the lab of Dr. I then moved to UNC at Chapel Hill to do postdoctoral work in the lab of Dr.
- Terry Hébert | Dr. GPCR Ecosystem
Terry Hebert on why challenge trials weren't ready, what it takes to hold a GPCR signaling lab together BRET platforms carry work forward when the lab can't. A lab is a social infrastructure, not just a physical one. Reopening is a puzzle about labs, not benches. Lab The GPCR Consortium PubMed Dr.
- Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Modern Research | Dr. GPCR Ecosystem
Jacob Lee and Jin Cho, co-founders of GeneMode, on the ten billion dollars American labs waste every His frustrations as a first-year graduate student navigating inaccessible lab software became the seed Access to the lab's tools is often rationed by seniority. Lab infrastructure is the hidden variable in drug discovery timelines. Private and shared workspaces both matter, even in collaborative labs.
- Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem
why "non-canonical" GPCRs are nature's own biased receptors, and building a structural pharmacology lab That moment of unplanned utility is a recurring theme in his lab. miss my theory classes to work in the lab. Bob Lefkowitz and asked him if he could join his lab at Duke University. Dr. Arun Shukla Lab Google Scholar PubMed Wikipedia LinkedIn Twitter Dr.
- Dr. John Janetzko | Dr. GPCR Ecosystem
At Harvard, I worked in the labs of Drs. To further develop these ideas, I joined the lab of Dr. He then moved to Dan's lab where he met Suzanne and her project. He chose Brian's lab due to his interest in studying conformational changes. John shared his experience of reaching out to and securing a position in Brian's lab.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental New Drug Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab They also discussed the relocation of some university labs to facilitate collaboration and overcome the
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental New Drug Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab They also discussed the relocation of some university labs to facilitate collaboration and overcome the
- Dr. Paul J. Gasser | Dr. GPCR Ecosystem
I received my PhD in Biology at Arizona State University, where I worked in the lab of Miles Orchinik My postdoctoral work, conducted at the University of Bristol, UK, in Christopher Lowry's lab, examined Research in my lab is currently focused on understanding the signal transduction pathways activated by Gasser on the web Gasser Lab Marquette University Google Scholar ResearchGate LinkedIn Twitter Dr.
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
Family B GPCRs evolved into a comprehensive resource for the GPCR research community — bridging wet-lab The lab’s early partnership with students like Emily Lorenzen catalyzed a transition from single-receptor This methodology was enhanced through collaboration with Jochen Schwenk’s lab at SciLifeLab in Karolinska Kotliar joined the Sakmar lab as a rotation student and immediately saw the project’s potential. Ilana’s research is multi-disciplinary and involves a close collaboration with the lab of proteomics
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
During his doctoral work in the lab of Prof. During his Cardiology fellowship, he trained in the lab of Dr. Robert J. The main focus of his lab’s research is on the mechanisms underlying biased agonism at chemokine receptors His lab is also interested in identifying novel signal transduction mechanisms of GPCRs, such as the
- Julia Gardner | Dr. GPCR Ecosystem
Julia has been working as a researcher in Duke's Rajagopal Lab since her first year as an undergraduate In the Rajagopal Lab, Julia studies the mechanisms of 'biased signaling' at GPCRs, with a specific focus Julia Gardner on the web Rajagopal Lab Google Scholar ResearchGate LinkedIn Dr.
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
His lab works on serotonin, dopamine, and opioid receptor structure, function, and drug discovery, with Roth's lab identified salvinorin A as a kappa opioid receptor agonist. A reminder of what scientific certainty sometimes looks like outside the lab. The arc from a lab "about as big as your car" at Case Western to leading a thirty-person GPCR lab at Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project
- Past Events by Dr. GPCR Ecosystem
GPCR: Beyond the lab GRS and GRC Switzerland GPCR Retreat 2023 Leadership is a learned skill - PhageMed GPCR: Beyond the lab Dr. GPCR: From idea to Ecosystem Dr. GPCR: Beyond the lab
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology Lab Facebook Group Twitter Semantic Scholar Instagram Neurotree Dimensions Reddit Dr
- Dr. Randy Hall | Dr. GPCR Ecosystem
1994, Randy moved to the Vollum Institute in Portland, Oregon, to do a post-doctoral fellowship in the laboratory Over the past two decades, his lab has published numerous groundbreaking findings shedding light on the Most recently, his lab has made a number of seminal contributions to understanding the signaling, regulation Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb Randy Hall on the web Hall Lab LinkedIn Google Scholar ResearchGate Dr. Lefkowitz Memoir. Dr.
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology Lab Facebook Group Twitter Semantic Scholar Instagram Neurotree Dimensions Reddit Dr
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology Lab Facebook Group Twitter Semantic Scholar Instagram Neurotree Dimensions Reddit Dr
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
reticulum, to the experimental frameworks that made biased agonism a credible drug discovery target - his lab personal loss that drew Bouvier toward the sympathetic nervous system, the postdoc in Bob Lefkowitz's lab biology revolution in GPCR science, and the foundational question that has guided every receptor his lab Every receptor his lab has studied was selected because it was the right model for a question that was developed in his lab to better understand GPCR structure/function relationships.
- Dr. Silvia Sposini | Dr. GPCR Ecosystem
mechanisms of GPCR action, namely dimerization and membrane trafficking, in Dr Aylin Hanyaloglu 's lab a postdoctoral fellowship from Wellcome Trust, working on a collaborative project (Dr Hanyaloglu's lab at ICL + Dr Perrais' lab at IINS) focused on understanding the interplay between GPCR signalling and





























